94664

Aerosol inhalation treatment; for acute airway obstruction, for therapeutic purposes and/or for diagnostic purposes to achieve bronchodilation

The supervised administration of aerosolized medication (e.g., bronchodilators) to a patient using a nebulizer or other inhalation device. This service is performed for therapeutic purposes, specifically to treat acute airway obstruction, or for diagnostic purposes to achieve bronchodilation. It is commonly utilized in the management of conditions such as acute exacerbations of asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis, or other acute respiratory conditions involving bronchospasm.

Clinical Indications

  • Acute exacerbation of asthma (e.g., asthma attack)
  • Acute exacerbation of chronic obstructive pulmonary disease (COPD)
  • Bronchiolitis with clinically significant airway obstruction
  • Croup with significant stridor or airway compromise requiring bronchodilation
  • Other acute respiratory conditions characterized by bronchospasm or reversible airway obstruction
  • Diagnostic bronchodilator challenge to assess reversibility of airway obstruction (e.g., as part of pulmonary function testing or in suspected asthma)

Procedure Steps

  1. Pre-treatment assessment of the patient's respiratory status, including vital signs, auscultation of lung sounds, and potentially objective measures like peak expiratory flow (PEF) or spirometry.
  2. Preparation of the prescribed aerosolized medication (e.g., albuterol, ipratropium bromide, levalbuterol) in the appropriate dosage and concentration.
  3. Selection and assembly of the appropriate aerosol delivery device (e.g., jet nebulizer, ultrasonic nebulizer, or metered-dose inhaler with spacer/holding chamber).
  4. Patient instruction on proper inhalation technique to ensure effective delivery and maximal therapeutic benefit of the medication.
  5. Supervised administration of the aerosol treatment, ensuring patient compliance, monitoring for adverse reactions, and adjusting delivery as needed.
  6. Post-treatment reassessment of the patient's respiratory status, including repeat vital signs, lung sounds, and objective measures like PEF or spirometry if clinically indicated.
  7. Documentation of the treatment details, including medication used, dosage, duration, patient tolerance, observed response to therapy, and any follow-up instructions.

Coding Guidelines

  • CPT code 94664 is reported per individual treatment session. If multiple distinct treatments are administered within the same encounter, each may be reported, subject to payer-specific frequency limitations and medical necessity.
  • This code generally includes the cost of the medication when administered in a physician office (non-facility) setting. In facility settings (e.g., hospital outpatient department), the medication itself may be billed separately by the facility pharmacy.
  • CPT 94664 is considered a therapeutic procedure and is typically separately reportable. If performed on the same day as an Evaluation and Management (E/M) service, modifier -25 may be appended to the E/M service if it represents a significant, separately identifiable service beyond the usual pre- and post-service work associated with the inhalation treatment.
  • Comprehensive documentation is essential, including the medical necessity for the treatment, the type and dosage of medication, the duration of the treatment, the patient's tolerance, and the patient's objective and subjective response to therapy.
  • Do not report 94664 for routine patient education on inhaler use, self-administered treatments without direct clinical supervision, or for continuous aerosolized treatments (which may be reported with different codes like 94640).

Associated ICD-10 Codes